University of Kansas Medical Center
Kansas City, Kansas, 66160, United States
NCT Number: NCT02921672
By doing this study, researchers hope to learn if older adults with and without cognitive impairment can adhere to a Mediterranean diet.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Kansas City, Kansas, 66160, United States
Participants will be given instruction on following the study designed Mediterranean diet. Participation in the study will last about 9 weeks. Each person will be asked to follow the study diet for 6 weeks. During the study, participants will be asked to track the food they eat and will be monitored by a registered dietitian.
Potential participants need to be located within the KC metro area.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Diet consisting of fruits, vegetables, grains, dairy, olive oils, seafood, and nuts. It is low in red meat and solid fats.
Time frame: Week 6
Determine feasibility of this patient population's ability to maintain the diet. Outcome will be measured by the number of participants who complete the entire study.
University of Kansas Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04445831
Alzheimer Disease, Alzheimer's Disease
Helsinki, Finland
View Trial DetailsNCT01354691
Alzheimer Disease, Alzheimer's Disease
Graz, Austria
View Trial DetailsNCT00814346
Alzheimer Disease, Alzheimer's Disease
Issy-les-Moulineaux, France
View Trial DetailsNCT01708304
Alzheimer Disease, Alzheimer's Disease
Seattle, Washington, United States
View Trial Details